Prime Medicine, Inc.PRMENASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank17
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-167.09M
↓ 76% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-95.01M
Historical baseline
PeriodValueYoY Change
2025$-167.09M-28.4%
2024$-130.16M+25.3%
2023$-174.14M-17.7%
2022$-147.92M-286.9%
2021$-38.23M-518.3%
2020$-6.18M-363.5%
2019$-1.33M-